Literature DB >> 1847089

Methods of detection of new families with X-linked lymphoproliferative disease.

D T Purtilo1, H L Grierson.   

Abstract

During the past decade, 240 males with X-linked lymphoproliferative disease (XLP) within 59 unrelated kindreds have been identified worldwide. One half of the patients have developed fatal infections mononucleosis, about one third have acquired hypogammaglobulinemia, and another one fourth have developed malignant lymphoma. Less commonly occurring phenotypes include hyperimmunoglobulinemia M, bone marrow hypoplasia, and necrotizing lymphoid vasculitis. The fatal infectious mononucleosis phenotype occurs at about 2.5 years of age, and median survival is only 33 days following onset of illness. The acquired hypogammaglobulinemia and malignant lymphoma phenotypes are associated with longer survivals, but to date no patient has been documented as living into the fifth decade of life. We summarized recent research findings and technological advances that permit accurate diagnosis of carrier females and detection of males with the XLP gene before Epstein-Barr virus infection.

Entities:  

Mesh:

Year:  1991        PMID: 1847089     DOI: 10.1016/0165-4608(91)90127-g

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  9 in total

1.  X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.

Authors:  Claire Booth; Kimberly C Gilmour; Paul Veys; Andrew R Gennery; Mary A Slatter; Helen Chapel; Paul T Heath; Colin G Steward; Owen Smith; Anna O'Meara; Hilary Kerrigan; Nizar Mahlaoui; Marina Cavazzana-Calvo; Alain Fischer; Despina Moshous; Stephane Blanche; Jana Pachlopnik Schmid; Jana Pachlopnick-Schmid; Sylvain Latour; Genevieve de Saint-Basile; Michael Albert; Gundula Notheis; Nikolaus Rieber; Brigitte Strahm; Henrike Ritterbusch; Arjan Lankester; Nico G Hartwig; Isabelle Meyts; Alessandro Plebani; Annarosa Soresina; Andrea Finocchi; Claudio Pignata; Emilia Cirillo; Sonia Bonanomi; Christina Peters; Krzysztof Kalwak; Srdjan Pasic; Petr Sedlacek; Janez Jazbec; Hirokazu Kanegane; Kim E Nichols; I Celine Hanson; Neena Kapoor; Elie Haddad; Morton Cowan; Sharon Choo; Joanne Smart; Peter D Arkwright; Hubert B Gaspar
Journal:  Blood       Date:  2010-10-06       Impact factor: 22.113

Review 2.  X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology.

Authors:  D T Purtilo
Journal:  Springer Semin Immunopathol       Date:  1991

3.  Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency.

Authors:  Rebecca A Marsh; Jack J Bleesing; Alexandra H Filipovich
Journal:  J Immunol Methods       Date:  2010-09-09       Impact factor: 2.303

4.  Molecular genetic haplotype segregation studies in three families with X-linked lymphoproliferative disease.

Authors:  V Schuster; S Seidenspinner; T Grimm; W Kress; S Zielen; M Bock; H W Kreth
Journal:  Eur J Pediatr       Date:  1994-06       Impact factor: 3.183

Review 5.  Epstein-Barr virus infection and associated diseases in children. I. Pathogenesis, epidemiology and clinical aspects.

Authors:  V Schuster; H W Kreth
Journal:  Eur J Pediatr       Date:  1992-10       Impact factor: 3.183

6.  Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency.

Authors:  Andrew L Snow; Rebecca A Marsh; Scott M Krummey; Philip Roehrs; Lisa R Young; Kejian Zhang; Jack van Hoff; Deepali Dhar; Kim E Nichols; Alexandra H Filipovich; Helen C Su; Jack J Bleesing; Michael J Lenardo
Journal:  J Clin Invest       Date:  2009-09-14       Impact factor: 14.808

7.  Characterization of clonality of Epstein-Barr virus-induced human B lymphoproliferative disease in mice with severe combined immunodeficiency.

Authors:  H Nakamine; A S Masih; M Okano; Y Taguchi; S J Pirruccello; J R Davis; M L Mahloch; K W Beisel; K Kleveland; W G Sanger
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

8.  The biology of HIV-associated lymphomas.

Authors:  M Bower
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

9.  Hematopoietic cell transplantation for asymptomatic X-linked lymphoproliferative syndrome type 1.

Authors:  Akihiro Tamura; Suguru Uemura; Nobuyuki Yamamoto; Atsuro Saito; Aiko Kozaki; Kenji Kishimoto; Toshiaki Ishida; Daiichiro Hasegawa; Haruka Hiroki; Tsubasa Okano; Kohsuke Imai; Tomohiro Morio; Hirokazu Kanegane; Yoshiyuki Kosaka
Journal:  Allergy Asthma Clin Immunol       Date:  2018-11-14       Impact factor: 3.406

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.